Introduction: Mesenchymal tumours of the bladder are benign but rare occurrences and represent approximately 1% of all bladder tumours.
Case Report: We report a case of a large bladder leiomyoma in an asymptomatic patient. A large pelvic mass was discovered incidentally on the bedside ultrasound scan during a review at the gynecology clinic. Intra-operatively, no mass was seen in the pelvis, and cystoscopy demonstrated an intravesical mass. It was further evaluated with cystoscopy. MR imaging demonstrated typical features of a bladder leiomyoma. Subsequently, the patient underwent partial cystectomy, and the mass was removed, which was histologically proven leiomyoma.
Conclusion: Awareness of this rare clinical entity and identification of its typical radiological features on MR imaging can aid with accurate diagnosis and preclude unnecessary radical surgery.
Leiomyoma of the bladder is an unusual cause of benign smooth muscle tumor, only reported about 250 times in the literature. Imaging studies including computed tomography (CT) and magnetic resonance imaging (MRI) scans are useful in defining the extent and location of the tumor, however, immunohistology samples must be obtained to rule out similar appearing cancerous masses. In this article, we report the case of a 50-year-old male diagnosed with leiomyoma of the bladder that initially presented as dysuria and raised suspicion of a bladder transitional cell carcinoma (TCC).
Background: Although blood urine is frequently observed in dromedary camels, little attention is gained and only it was reported as case reports.
Aim: This study was carried out to examine dromedary camels suffering from red urine syndrome from the points of clinical, etiological, hematobiochemical, ultrasonographic, and pathological characteristics.
Methods: Thirty-one camels with red urine and fifteen controls were enrolled.
Introduction: Bladder leiomyomas (LM) are uncommon, non-cancerous growths that originate from the smooth muscle cells of the bladder and constitute 0.5% of bladder tumor cases. This review aims to compile existing data and present a summary of bladder leiomyomas' characteristics, management, and related outcomes.
The study aimed to assess the safety and effectiveness of various doses of mifepristone (2.5 mg to 50 mg) in treating uterine fibroids through a systematic review of randomized controlled trials (RCTs).
A meta-analysis of 18 studies involving 2,066 patients indicated that mifepristone significantly reduced uterine and fibroid volumes and improved symptoms like pelvic pain and urinary issues compared to a control group.
While mifepristone showed benefits, it also caused some side effects such as increased endometrial thickness and hot flashes, with the 5 mg/day dose for three months being identified as the potentially best regimen for treatment.
Prostate leiomyoma is a rare benign tumor that is often diagnosed post-surgery, with management primarily involving transurethral resection due to lack of established guidelines.
A patient presented with urinary issues and was found to have prostate leiomyoma after imaging and prior related medical history, leading to a successful holmium laser enucleation procedure.
Post-surgery, the patient showed no recurrence and is under regular monitoring, emphasizing the importance of patient follow-up and timely intervention for this rare condition.
